Literature DB >> 8420385

Neuro-ophthalmologic findings in chordoma and chondrosarcoma of the skull base.

N J Volpe1, N J Liebsch, J E Munzenrider, S Lessell.   

Abstract

Review of the clinical features of 48 patients with chordoma and 49 patients with low-grade chondrosarcoma of the skull base disclosed overlapping clinical profiles but distinctive features. Both tumors occurred at all ages but chondrosarcoma tended to occur in the third and fourth decades. Twenty-five (52%) of the patients with chordoma and 24 (49%) of the patients with chondrosarcoma had ocular symptoms (diplopia or visual impairment) as the initial manifestation of the disease. Of the 59 patients (both groups) with diplopia, the diplopia was initially intermittent in 25 (42%). Headache and diplopia from an insidious abducens nerve palsy was most common in both groups. Abducens nerve palsy occurred in 22 (46%) of the patients with chordoma and 23 (47%) of the patients with chondrosarcoma. Normal examination results were more common in patients with chordoma, whereas visual loss, facial numbness, and multiple cranial neuropathies were more common in patients with chondrosarcoma. The similarities in the clinical features of these tumors reflect their common origin at the central skull base and the vulnerability of the abducens nerves at that site. The differences reflect the tendency of chordomas to originate from the clivus and chondrosarcomas to originate from the temporal bone.

Entities:  

Mesh:

Year:  1993        PMID: 8420385     DOI: 10.1016/s0002-9394(14)73531-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  19 in total

Review 1.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

2.  Metastatic disease to the clivus mimicking clival chordomas.

Authors:  Adam S Deconde; Yas Sanaiha; Jeffrey D Suh; Sunita Bhuta; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2013-06-26

Review 3.  Proton therapy for tumors of the skull base.

Authors:  J E Munzenrider; N J Liebsch
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

4.  Gamma Knife Stereotactic Radiosurgery for the treatment of chordomas and chondrosarcomas.

Authors:  Julian Cahill; Ramez Ibrahim; Geza Mezey; John Yianni; Debapriya Bhattacharyya; Lee Walton; Alison Grainger; Matthias W R Radatz
Journal:  Acta Neurochir (Wien)       Date:  2021-02-19       Impact factor: 2.216

5.  Surgical treatment of skull base chondrosarcomas.

Authors:  Amir Samii; Venelin Gerganov; Christian Herold; Alireza Gharabaghi; Nakamasa Hayashi; Madjid Samii
Journal:  Neurosurg Rev       Date:  2008-09-26       Impact factor: 3.042

Review 6.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.

Authors:  Brian J Jian; Orin G Bloch; Isaac Yang; Seunggu J Han; Derick Aranda; Tarik Tihan; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-12-02       Impact factor: 4.130

7.  Update on the cytogenetics and molecular genetics of chordoma.

Authors:  Lidia Larizza; Pietro Mortini; Paola Riva
Journal:  Hered Cancer Clin Pract       Date:  2005-02-15       Impact factor: 2.857

8.  Endoscopic surgery of skull base chordomas.

Authors:  Neil C-W Tan; Yuresh Naidoo; Sakiko Oue; Hamish Alexander; Simon Robinson; Agadha Wickremesekera; Steve Floreani; Nick Vrodos; Steve Santoreneos; Eng Ooi; Matthew McDonald; Peter-John Wormald
Journal:  J Neurol Surg B Skull Base       Date:  2012-08-29

9.  Unusual presentation of non-small cell lung cancer with clival metastases: Case report.

Authors:  Fawzi Abu Hijla; Sameer Yaser; Kamal Al-Rabi; Akram Al-Ibraheem; Omar Khzouz; Laith Al Khairi; Hamza Ghatasheh; Ayat Al-Oqaily; Jamal Khader
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-17

10.  Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute.

Authors:  Rohan L Deraniyagala; Daniel Yeung; William M Mendenhall; Zuofeng Li; Christopher G Morris; Nancy P Mendenhall; Paul Okunieff; Robert S Malyapa
Journal:  J Neurol Surg B Skull Base       Date:  2013-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.